| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Pacific Biosciences (NASDAQ:PACB) through any online brokerage.
Other companies in Pacific Biosciences’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Pacific Biosciences has a consensus price target of $2.30.
The stock price for Pacific Biosciences (NASDAQ: PACB) is $2.7 last updated October 6, 2026 at 4:14 PM EDT.
There are no upcoming dividends for Pacific Biosciences.
Pacific Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Pacific Biosciences.
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
